Caitong International Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.53K	Buy	102 +74	+264%	+$1.11K	﹤0.01%	1464
2025 Q1	$452	Buy	28 +14	+100%	+$226	﹤0.01%	1800
2024 Q4	$326	Buy	+14	New	+$326	﹤0.01%	1526